1Soffietti R, Rud8 R, Mutani R. Management of brain metas-tases [J]. J Neurol, 2002, 249(10): 1357-1369.
2Terae S, Yoshida D, Kudo K, et al. Contrast-enhanced FLAIR imaging in combination with pre-and postcontrast magnetization transfer T2-weighted imaging., usefulness in the evaluation of brain metastases [J]. Magn Reson Imaging, 2007, 25(3): 479-487.
3Kim SY, Kim JS, Park HS, et al. Screening of brain metasta- sis with limited magnetic resonance imaging (MRI): clinical iraplieatians of using limited brain MRI during initial staging for non-small cell lung cancer patients [J]. J Korean Med Sci, 2005, 20(1): 121-126.
4Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent dif- fusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies [J]. AJNR, 2008, 29(3): 476- 482.
5Lee YY, Wong KT, King AD, et al. Imaging of salivary gland tumors [J]. Eur J Radiol, 2008, 66(3): 4:19-436.
6Wang W, Steward CE, Desmond PM. Diffusion tensor ima- ging in glioblas-toma multiforme and brain metastases: the role of p,q,1, and fractional anisotropy [J]. AJNR, 2009, 30 (1) : 203-208.
